CRSP
CRISPR THERAP N (CRSP)
NASDAQ
$51.77+$0.05 (+0.09%)
Price as of Sep 11, 2026 7:47 PM EDT
  • $5.1B
    Market Cap
  • -8.07%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 5
Valuation
CRSP
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 35
Valuation
CRSP
vs History
vs S&P 500
3-Month Momentum
4.88%
12-Month Momentum
-3.40%
3-Month Risk Adjusted Momentum
24.59%
12-Month Risk Adjusted Momentum
-5.97%

True Yield

N/A
Valuation
CRSP
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-0.71%
Net Debt Paydown Yield
-0.01%

Financial Health Score

Score: 55
Valuation
CRSP
vs History
vs S&P 500
Ohlson's O-Score
7